Table 1 IDEA study eligibility criteria
Study component | Inclusion criteria | Exclusion criteria |
|---|---|---|
SMART | • Diagnosed with type 1 or type 2 diabetes • 18 years of age or older • Able to provide informed consent • African American/Black or Latine • HbA1c level ≥ 7% measured within 365 days prior to study enrollment • Have a smartphone compatible with the Glooko RGM application [20] • Completed at least one appointment at the Center since the Center opened in 2020 • Fluent in English or Spanish | • Have an activated Power of Attorney • Diagnosed with Stage V renal disease or undergoing dialysis • Diagnosed with a severe form of cardiovascular disease • Diagnosed with gestational diabetes only (without type 1 or type 2) • Diagnosed with any severe form of mental disorder including schizophrenia, bipolar disorder, or severe depression • Pregnant • Diagnosed with Alzheimer’s disease or dementia • Already an active user of RGM • Actively working with a CHW for their diabetes • Planning to travel outside of the Chicagoland area for more than three months in the year following study enrollment • Use a continuous glucose monitor that is incompatible with the Glooko RGM application |
Participant Focus Group Discussions | • Meet all eligibility for SMART component of study • Completed at least 3 months of their assigned SMART study condition | None |
Center Staff Interviews | • Employed by the Center during the study period • 18 years of age or older • Able to provide informed consent • Fluent in English or Spanish | None |